1 | six | 24,908 |
2 | diestrous | 4 |
3 | twelve- | 4 |
4 | 3744 | 3 |
5 | moderate-severity | 3 |
6 | sd≥6 | 3 |
7 | 0.0617 | 2 |
8 | 13,654 | 2 |
9 | 7517 | 2 |
10 | at12 | 2 |
11 | pfs≥7 | 2 |
12 | 0-6-12 | 1 |
13 | 0.1203 | 1 |
14 | 0.3-30.6 | 1 |
15 | 0~3 | 1 |
16 | 1.0±2.6 | 1 |
17 | 1.9-s | 1 |
18 | 10.0±9.8 | 1 |
19 | 10.7+/-1.2 | 1 |
20 | 11.0±2.1 | 1 |
21 | 11.2+/-6.4 | 1 |
22 | 113±69 | 1 |
23 | 12,174 | 1 |
24 | 12-48.5 | 1 |
25 | 12-66 | 1 |
26 | 12.0-24.2 | 1 |
27 | 12.2-12.6 | 1 |
28 | 12.6-28.3 | 1 |
29 | 13,7 | 1 |
30 | 13.2±16.1 | 1 |
31 | 13.8±8.6 | 1 |
32 | 14.5±6.5 | 1 |
33 | 14.8+/-1.4 | 1 |
34 | 143.35 | 1 |
35 | 15.9+/-4.5 | 1 |
36 | 158-216 | 1 |
37 | 15±11 | 1 |
38 | 15×2-min | 1 |
39 | 16+/-12 | 1 |
40 | 16+/-13 | 1 |
41 | 16.9-40.1 | 1 |
42 | 16.9/11.9 | 1 |
43 | 18+/-11 | 1 |
44 | 18.0+/-4.4 | 1 |
45 | 18.5±11.16 | 1 |
46 | 18±11 | 1 |
47 | 19-d | 1 |
48 | 19.7±5.2 | 1 |
49 | 20.1±13.3 | 1 |
50 | 20.7±11.5 | 1 |
51 | 207/297 | 1 |
52 | 20±14 | 1 |
53 | 21+/-12 | 1 |
54 | 21.1±5.5 | 1 |
55 | 214,276 | 1 |
56 | 22.1354 | 1 |
57 | 22.9+/-8.4 | 1 |
58 | 24.6+/-2.4 | 1 |
59 | 25.5±25.1 | 1 |
60 | 259,200 | 1 |
61 | 26.6+/-15.9 | 1 |
62 | 27+/-17 | 1 |
63 | 27.7±20.3 | 1 |
64 | 29+/-25 | 1 |
65 | 29+/-27 | 1 |
66 | 29.3+/-4.6 | 1 |
67 | 3,6,12 | 1 |
68 | 3-58 | 1 |
69 | 3-84 | 1 |
70 | 3.5log | 1 |
71 | 30+/-18 | 1 |
72 | 30.0+/-12.1 | 1 |
73 | 31+/-19 | 1 |
74 | 31+/-29 | 1 |
75 | 32+/-12 | 1 |
76 | 32-144 | 1 |
77 | 33-120 | 1 |
78 | 33.1±14.8 | 1 |
79 | 34+/-23 | 1 |
80 | 35+/-22 | 1 |
81 | 35.6+/-1.7 | 1 |
82 | 36,5 | 1 |
83 | 37,861 | 1 |
84 | 38+/-25 | 1 |
85 | 4-137 | 1 |
86 | 40±20 | 1 |
87 | 41.9±9.4 | 1 |
88 | 42.9±11 | 1 |
89 | 43+/-15 | 1 |
90 | 43.83 | 1 |
91 | 44+ | 1 |
92 | 44+/-28 | 1 |
93 | 45+/-37 | 1 |
94 | 45,130 | 1 |
95 | 48±36 | 1 |
96 | 5,004 | 1 |
97 | 5.7-13.5 | 1 |
98 | 50±23 | 1 |
99 | 56.0±42.6 | 1 |
100 | 6-142 | 1 |
101 | 62+/-13 | 1 |
102 | 66±28 | 1 |
103 | 69+/-45 | 1 |
104 | 69,675 | 1 |
105 | 7,08 | 1 |
106 | 7-1/2 | 1 |
107 | 7-217 | 1 |
108 | 7.8-8.6 | 1 |
109 | 71±48 | 1 |
110 | 84.4±15 | 1 |
111 | 88.3±66 | 1 |
112 | 9+/-7 | 1 |
113 | 9.4±3.8 | 1 |
114 | 9.6±1.9 | 1 |
115 | 9–36 | 1 |
116 | after13 | 1 |
117 | amrahia | 1 |
118 | baseline-0-23 | 1 |
119 | cellulose-only | 1 |
120 | clomiphene-induction | 1 |
121 | dissolution-crystallization | 1 |
122 | fall-spring | 1 |
123 | four-second | 1 |
124 | hyperpolarization/depolarization | 1 |
125 | once-every-3 | 1 |
126 | onset=17.62 | 1 |
127 | patients.-16 | 1 |
128 | peform | 1 |
129 | prespawning | 1 |
130 | prewritten | 1 |
131 | six-nine | 1 |
132 | six-twelve | 1 |
133 | supplementation.all | 1 |
134 | tfi≤3 | 1 |
135 | those≥6 | 1 |
136 | three-to-four | 1 |
1 | 0-6-12 | 1 |
2 | 0.0617 | 2 |
3 | 0.1203 | 1 |
4 | 0.3-30.6 | 1 |
5 | 0~3 | 1 |
6 | 1.0±2.6 | 1 |
7 | 1.9-s | 1 |
8 | 10.0±9.8 | 1 |
9 | 10.7+/-1.2 | 1 |
10 | 11.0±2.1 | 1 |
11 | 11.2+/-6.4 | 1 |
12 | 113±69 | 1 |
13 | 12,174 | 1 |
14 | 12-48.5 | 1 |
15 | 12-66 | 1 |
16 | 12.0-24.2 | 1 |
17 | 12.2-12.6 | 1 |
18 | 12.6-28.3 | 1 |
19 | 13,654 | 2 |
20 | 13,7 | 1 |
21 | 13.2±16.1 | 1 |
22 | 13.8±8.6 | 1 |
23 | 14.5±6.5 | 1 |
24 | 14.8+/-1.4 | 1 |
25 | 143.35 | 1 |
26 | 15.9+/-4.5 | 1 |
27 | 158-216 | 1 |
28 | 15±11 | 1 |
29 | 15×2-min | 1 |
30 | 16+/-12 | 1 |
31 | 16+/-13 | 1 |
32 | 16.9-40.1 | 1 |
33 | 16.9/11.9 | 1 |
34 | 18+/-11 | 1 |
35 | 18.0+/-4.4 | 1 |
36 | 18.5±11.16 | 1 |
37 | 18±11 | 1 |
38 | 19-d | 1 |
39 | 19.7±5.2 | 1 |
40 | 20.1±13.3 | 1 |
41 | 20.7±11.5 | 1 |
42 | 207/297 | 1 |
43 | 20±14 | 1 |
44 | 21+/-12 | 1 |
45 | 21.1±5.5 | 1 |
46 | 214,276 | 1 |
47 | 22.1354 | 1 |
48 | 22.9+/-8.4 | 1 |
49 | 24.6+/-2.4 | 1 |
50 | 25.5±25.1 | 1 |
51 | 259,200 | 1 |
52 | 26.6+/-15.9 | 1 |
53 | 27+/-17 | 1 |
54 | 27.7±20.3 | 1 |
55 | 29+/-25 | 1 |
56 | 29+/-27 | 1 |
57 | 29.3+/-4.6 | 1 |
58 | 3,6,12 | 1 |
59 | 3-58 | 1 |
60 | 3-84 | 1 |
61 | 3.5log | 1 |
62 | 30+/-18 | 1 |
63 | 30.0+/-12.1 | 1 |
64 | 31+/-19 | 1 |
65 | 31+/-29 | 1 |
66 | 32+/-12 | 1 |
67 | 32-144 | 1 |
68 | 33-120 | 1 |
69 | 33.1±14.8 | 1 |
70 | 34+/-23 | 1 |
71 | 35+/-22 | 1 |
72 | 35.6+/-1.7 | 1 |
73 | 36,5 | 1 |
74 | 37,861 | 1 |
75 | 3744 | 3 |
76 | 38+/-25 | 1 |
77 | 4-137 | 1 |
78 | 40±20 | 1 |
79 | 41.9±9.4 | 1 |
80 | 42.9±11 | 1 |
81 | 43+/-15 | 1 |
82 | 43.83 | 1 |
83 | 44+ | 1 |
84 | 44+/-28 | 1 |
85 | 45+/-37 | 1 |
86 | 45,130 | 1 |
87 | 48±36 | 1 |
88 | 5,004 | 1 |
89 | 5.7-13.5 | 1 |
90 | 50±23 | 1 |
91 | 56.0±42.6 | 1 |
92 | 6-142 | 1 |
93 | 62+/-13 | 1 |
94 | 66±28 | 1 |
95 | 69+/-45 | 1 |
96 | 69,675 | 1 |
97 | 7,08 | 1 |
98 | 7-1/2 | 1 |
99 | 7-217 | 1 |
100 | 7.8-8.6 | 1 |
101 | 71±48 | 1 |
102 | 7517 | 2 |
103 | 84.4±15 | 1 |
104 | 88.3±66 | 1 |
105 | 9+/-7 | 1 |
106 | 9.4±3.8 | 1 |
107 | 9.6±1.9 | 1 |
108 | 9–36 | 1 |
109 | after13 | 1 |
110 | amrahia | 1 |
111 | at12 | 2 |
112 | baseline-0-23 | 1 |
113 | cellulose-only | 1 |
114 | clomiphene-induction | 1 |
115 | diestrous | 4 |
116 | dissolution-crystallization | 1 |
117 | fall-spring | 1 |
118 | four-second | 1 |
119 | hyperpolarization/depolarization | 1 |
120 | moderate-severity | 3 |
121 | once-every-3 | 1 |
122 | onset=17.62 | 1 |
123 | patients.-16 | 1 |
124 | peform | 1 |
125 | pfs≥7 | 2 |
126 | prespawning | 1 |
127 | prewritten | 1 |
128 | sd≥6 | 3 |
129 | six | 24,908 |
130 | six-nine | 1 |
131 | six-twelve | 1 |
132 | supplementation.all | 1 |
133 | tfi≤3 | 1 |
134 | those≥6 | 1 |
135 | three-to-four | 1 |
136 | twelve- | 4 |
1 | 44+ | 1 |
2 | twelve- | 4 |
3 | 259,200 | 1 |
4 | 33-120 | 1 |
5 | 40±20 | 1 |
6 | 45,130 | 1 |
7 | 16.9-40.1 | 1 |
8 | 30.0+/-12.1 | 1 |
9 | 11.0±2.1 | 1 |
10 | 25.5±25.1 | 1 |
11 | 13.2±16.1 | 1 |
12 | 18+/-11 | 1 |
13 | 15±11 | 1 |
14 | 18±11 | 1 |
15 | 42.9±11 | 1 |
16 | 37,861 | 1 |
17 | 10.7+/-1.2 | 1 |
18 | 12.0-24.2 | 1 |
19 | 19.7±5.2 | 1 |
20 | 7-1/2 | 1 |
21 | 3,6,12 | 1 |
22 | 21+/-12 | 1 |
23 | 32+/-12 | 1 |
24 | 16+/-12 | 1 |
25 | 0-6-12 | 1 |
26 | at12 | 2 |
27 | 35+/-22 | 1 |
28 | 6-142 | 1 |
29 | onset=17.62 | 1 |
30 | once-every-3 | 1 |
31 | 27.7±20.3 | 1 |
32 | 20.1±13.3 | 1 |
33 | 12.6-28.3 | 1 |
34 | 0.1203 | 1 |
35 | 62+/-13 | 1 |
36 | 16+/-13 | 1 |
37 | after13 | 1 |
38 | 34+/-23 | 1 |
39 | baseline-0-23 | 1 |
40 | 50±23 | 1 |
41 | 43.83 | 1 |
42 | 0~3 | 1 |
43 | tfi≤3 | 1 |
44 | 14.8+/-1.4 | 1 |
45 | 24.6+/-2.4 | 1 |
46 | 18.0+/-4.4 | 1 |
47 | 11.2+/-6.4 | 1 |
48 | 22.9+/-8.4 | 1 |
49 | 41.9±9.4 | 1 |
50 | 5,004 | 1 |
51 | 20±14 | 1 |
52 | 32-144 | 1 |
53 | 3744 | 3 |
54 | 22.1354 | 1 |
55 | 13,654 | 2 |
56 | 12,174 | 1 |
57 | 3-84 | 1 |
58 | 36,5 | 1 |
59 | 20.7±11.5 | 1 |
60 | 5.7-13.5 | 1 |
61 | 15.9+/-4.5 | 1 |
62 | 21.1±5.5 | 1 |
63 | 14.5±6.5 | 1 |
64 | 12-48.5 | 1 |
65 | 43+/-15 | 1 |
66 | 84.4±15 | 1 |
67 | 38+/-25 | 1 |
68 | 29+/-25 | 1 |
69 | 143.35 | 1 |
70 | 69+/-45 | 1 |
71 | 69,675 | 1 |
72 | 0.3-30.6 | 1 |
73 | 12.2-12.6 | 1 |
74 | 56.0±42.6 | 1 |
75 | 1.0±2.6 | 1 |
76 | 29.3+/-4.6 | 1 |
77 | 7.8-8.6 | 1 |
78 | 13.8±8.6 | 1 |
79 | patients.-16 | 1 |
80 | 18.5±11.16 | 1 |
81 | 158-216 | 1 |
82 | 9–36 | 1 |
83 | 48±36 | 1 |
84 | 12-66 | 1 |
85 | 88.3±66 | 1 |
86 | 214,276 | 1 |
87 | sd≥6 | 3 |
88 | those≥6 | 1 |
89 | 13,7 | 1 |
90 | 9+/-7 | 1 |
91 | 35.6+/-1.7 | 1 |
92 | 27+/-17 | 1 |
93 | 7-217 | 1 |
94 | 7517 | 2 |
95 | 0.0617 | 2 |
96 | 29+/-27 | 1 |
97 | 45+/-37 | 1 |
98 | 4-137 | 1 |
99 | 207/297 | 1 |
100 | pfs≥7 | 2 |
101 | 9.4±3.8 | 1 |
102 | 33.1±14.8 | 1 |
103 | 10.0±9.8 | 1 |
104 | 7,08 | 1 |
105 | 30+/-18 | 1 |
106 | 44+/-28 | 1 |
107 | 66±28 | 1 |
108 | 71±48 | 1 |
109 | 3-58 | 1 |
110 | 16.9/11.9 | 1 |
111 | 9.6±1.9 | 1 |
112 | 26.6+/-15.9 | 1 |
113 | 31+/-19 | 1 |
114 | 31+/-29 | 1 |
115 | 113±69 | 1 |
116 | amrahia | 1 |
117 | 19-d | 1 |
118 | four-second | 1 |
119 | six-nine | 1 |
120 | six-twelve | 1 |
121 | prespawning | 1 |
122 | fall-spring | 1 |
123 | 3.5log | 1 |
124 | supplementation.all | 1 |
125 | peform | 1 |
126 | prewritten | 1 |
127 | 15×2-min | 1 |
128 | dissolution-crystallization | 1 |
129 | hyperpolarization/depolarization | 1 |
130 | clomiphene-induction | 1 |
131 | three-to-four | 1 |
132 | 1.9-s | 1 |
133 | diestrous | 4 |
134 | six | 24,908 |
135 | cellulose-only | 1 |
136 | moderate-severity | 3 |